Moscow/Sputnik: Public health officials in England have called on general practitioners to begin staffing local COVID-19 vaccination centers by December 14, the Sky News broadcaster repor ...
Washington/Sputnik: US drug giant Pfizer expects to ship just about half of the COVID-19 vaccines it originally planned for this year because of supply-chain problems, although it still e ...
New York: Along with other tried and tested public health measures, the head of the World Health Organization (WHO) told journalists on Monday that “there is now real hope” th ...
New York: UN Children’s Fund (UNICEF) is working with more than 350 logistics partners, including major airlines, shipping lines and logistics associations from around the world, to ...
London: Oxford University’s AstraZeneca vaccine candidate, AZD1222, which is being developed against COVID-19 disease has shown 70 percent efficiency on average, officials said.
Moscow/Sputnik: The first US citizens to receive Pfizer's COVID-19 vaccines may get the inoculation shot December 11, Operation Warp Speed chief adviser Moncef Slaoui told CNN on Sund ...
Moscow/Sputnik: US pharmaceutical company Pfizer announced in a press release on Tuesday it was launching a pilot program that aims to inform the delivery and distribution of its coronavi ...
London/Sputnik: UK Medicines and Healthcare products Regulatory Agency (MHRA) chief executive, June Raine, said on Wednesday that any potential COVID-19 vaccine must meet the highest stan ...
Moscow/Sputnik: All Russia's vaccines against COVID-19 are efficient, President Vladimir Putin assured on Tuesday, reaffirming readiness to cooperate with any country on the coronavir ...
- 91 countries now offer COVID-19 vaccinations to refugees, says UNHCR
- Bangladesh: Authorities clear homegrown Bangavax coronavirus vaccine for clinical trial with conditions
- COVID-19 cases drop for seventh week, but deaths fall less slowly: WHO
- Two doses of COVID-19 vaccines are highly effective against hospitalisation from Delta variant: PHE
- WHO warns of ‘two-track pandemic’ as cases decline but vaccine inequity persists